Vistin Pharma ASA: Mandatory notification of trade
September 26, 2024 11:27 ET
|
Vistin Pharma ASA
Saga Pure ASA has on 26 September 2024 purchased 50,000 shares in Vistin Pharma ASA at NOK 28.2 per share. After the transaction Saga Pure ASA has a holding of 700,000 shares, corresponding to 1.58%...
Disclosure of large shareholding and mandatory notification of trade in Vistin Pharma ASA
September 13, 2024 11:10 ET
|
Vistin Pharma ASA
Saga Pure ASA has on 13 September 2024 purchased 250,000 shares in Vistin Pharma ASA at NOK 25.13 per share. After the transaction Saga Pure ASA has a holding of 650,000 shares, corresponding to 1.47%...
Vistin Pharma ASA: Mandatory notification of trade
August 23, 2024 10:06 ET
|
Vistin Pharma ASA
Saga Pure ASA has on 23 August 2024 purchased 300,000 shares in Vistin Pharma ASA at NOK 22,50 per share. After the transaction Saga Pure ASA has a holding of 400,000 shares, corresponding to 0.9 %...
Vistin Pharma ASA: Second quarter and first half 2024 financial results
August 23, 2024 01:40 ET
|
Vistin Pharma ASA
Oslo, Norway, 23rd of August 2024 Vistin Pharma ASA (VISTN) today announces the financial results for the second quarter of 2024. Revenue in the second quarter ended at MNOK 106 compared to MNOK...
Vistin Pharma ASA: Invitation to Q2 2024 conference call
August 16, 2024 04:00 ET
|
Vistin Pharma ASA
Oslo, Norway, 16 August 2024 Vistin Pharma ASA will release its second quarter and YTD 2024 results on Friday 23rd of August 2024. Vistin Pharma will host a conference call for all shareholders and...
Ex dividend NOK 0.50 today
June 05, 2024 02:05 ET
|
Vistin Pharma ASA
The shares in Vistin Pharma ASA will be traded ex dividend NOK 0.50 as from today, 05.06.2024. ...
Vistin Pharma ASA: Minutes from the annual general meeting 2024
May 23, 2024 08:50 ET
|
Vistin Pharma ASA
Oslo, Norway, 23 May 2024 Vistin Pharma ASA (OSE: VISTN), please find attached the minutes from the annual general meeting held today, on the 23 May 2024. All matters were resolved as proposed in...
Disclosure of voting rights at AGM in Vistin Pharma ASA
May 23, 2024 06:56 ET
|
Vistin Pharma ASA
Oslo, Norway, 23 May 2024 In relation to the Annual General Meeting in Vistin Pharma ASA (OSE: VISTN), on the 23th of May, the Company's Chair of the Board, Øyvin Brøymer, has received open...
Vistin Pharma ASA: Notice of Annual General Meeting 23 May 2024
April 30, 2024 02:58 ET
|
Vistin Pharma ASA
Oslo, Norway, 30 April 2024 Vistin Pharma ASA (OSE: VISTN), please find attached the call for the Annual General Meeting in Vistin Pharma, to be held on 23 May 2024 at 13:00 CEST. A physical...
Vistin Pharma ASA: Annual Report 2023
April 24, 2024 17:10 ET
|
Vistin Pharma ASA
Oslo, Norway, 24 April 2024 Please find attached the Annual Report for 2023 for Vistin Pharma ASA. There are no material changes in the financial statements compared to the preliminary full...